These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 17320297)

  • 1. Insulin-like growth factor type I biology and targeting in malignant gliomas.
    Trojan J; Cloix JF; Ardourel MY; Chatel M; Anthony DD
    Neuroscience; 2007 Mar; 145(3):795-811. PubMed ID: 17320297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New treatment strategies for malignant gliomas.
    Sathornsumetee S; Rich JN
    Expert Rev Anticancer Ther; 2006 Jul; 6(7):1087-104. PubMed ID: 16831080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell proliferation and migration in glioblastoma multiforme cell lines are influenced by insulin-like growth factor I in vitro.
    Schlenska-Lange A; Knüpfer H; Lange TJ; Kiess W; Knüpfer M
    Anticancer Res; 2008; 28(2A):1055-60. PubMed ID: 18507054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting epidermal growth factor receptor variant III: a novel strategy for the therapy of malignant glioma.
    Sonabend AM; Dana K; Lesniak MS
    Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S45-50. PubMed ID: 18076318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IGF-I: from diagnostic to triple-helix gene therapy of solid tumors.
    Trojan LA; Kopinski P; Wei MX; Ly A; Glogowska A; Czarny J; Shevelev A; Przewlocki R; Henin D; Trojan J
    Acta Biochim Pol; 2002; 49(4):979-90. PubMed ID: 12545204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular neuro-oncology and development of targeted therapeutic strategies for brain tumors. Part 1: Growth factor and Ras signaling pathways.
    Newton HB
    Expert Rev Anticancer Ther; 2003 Oct; 3(5):595-614. PubMed ID: 14599084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGF-I triple helix gene therapy of rat and human gliomas.
    Trojan LA; Kopinski P; Mazurek A; Chyczewski L; Ly A; Jarocki P; Nikliński J; Shevelev A; Trzos R; Pan Y; Gitis DJ; Bierwagen M; Czapiewska JL; Wei MX; Michalkiewicz J; Henin D; Popiela T; Evrard F; Kasprzak H; Anthony D; Trojan J
    Rocz Akad Med Bialymst; 2003; 48():18-27. PubMed ID: 14737936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor receptor - mediated signal transduction in the development and therapy of gliomas.
    Nicholas MK; Lukas RV; Jafri NF; Faoro L; Salgia R
    Clin Cancer Res; 2006 Dec; 12(24):7261-70. PubMed ID: 17189397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecularly targeted therapy for malignant glioma.
    Sathornsumetee S; Reardon DA; Desjardins A; Quinn JA; Vredenburgh JJ; Rich JN
    Cancer; 2007 Jul; 110(1):13-24. PubMed ID: 17520692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microglia-derived TGF-beta as an important regulator of glioblastoma invasion--an inhibition of TGF-beta-dependent effects by shRNA against human TGF-beta type II receptor.
    Wesolowska A; Kwiatkowska A; Slomnicki L; Dembinski M; Master A; Sliwa M; Franciszkiewicz K; Chouaib S; Kaminska B
    Oncogene; 2008 Feb; 27(7):918-30. PubMed ID: 17684491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial cell barrier impairment induced by glioblastomas and transforming growth factor beta2 involves matrix metalloproteinases and tight junction proteins.
    Ishihara H; Kubota H; Lindberg RL; Leppert D; Gloor SM; Errede M; Virgintino D; Fontana A; Yonekawa Y; Frei K
    J Neuropathol Exp Neurol; 2008 May; 67(5):435-48. PubMed ID: 18431253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular advances of brain tumors in radiation oncology.
    Noda SE; El-Jawahri A; Patel D; Lautenschlaeger T; Siedow M; Chakravarti A
    Semin Radiat Oncol; 2009 Jul; 19(3):171-8. PubMed ID: 19464632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The biology of gliomas: growth factors and oncogene expression. A current review].
    Westphal M; Herrmann HD
    Fortschr Neurol Psychiatr; 1988 Feb; 56(2):59-66. PubMed ID: 3283009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor.
    Shibuya M
    FEBS J; 2009 Sep; 276(17):4636-43. PubMed ID: 19664071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy for malignant glioma.
    Lesniak MS
    Expert Rev Neurother; 2006 Apr; 6(4):479-88. PubMed ID: 16623647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial review: targets for glioma treatment: from bench to bedside.
    Sanson M
    Curr Opin Oncol; 2008 Nov; 20(6):650-1. PubMed ID: 18841046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of novel targeted therapies in the treatment of malignant glioma.
    Rich JN; Bigner DD
    Nat Rev Drug Discov; 2004 May; 3(5):430-46. PubMed ID: 15136790
    [No Abstract]   [Full Text] [Related]  

  • 18. Angiogenesis and anti-angiogenic molecularly targeted therapies in malignant gliomas.
    Argyriou AA; Giannopoulou E; Kalofonos HP
    Oncology; 2009; 77(1):1-11. PubMed ID: 19439998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of apoptosis in human multiple myeloma by insulin-like growth factor I (IGF-I).
    Jernberg-Wiklund H; Nilsson K
    Adv Cancer Res; 2007; 97():139-65. PubMed ID: 17419944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multivariate analysis of patients with brain tumors treated with ATN-RNA.
    Wyszko E; Rolle K; Nowak S; Zukiel R; Nowak M; Piestrzeniewicz R; Gawrońska I; Barciszewska MZ; Barciszewski J
    Acta Pol Pharm; 2008; 65(6):677-84. PubMed ID: 19172848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.